DOCEBO INC (DCBO) Fundamental Analysis & Valuation

NASDAQ:DCBO • CA25609L1058

Current stock price

16.64 USD
-1.04 (-5.88%)
Last:

This DCBO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DCBO Profitability Analysis

1.1 Basic Checks

  • DCBO had positive earnings in the past year.
  • DCBO had a positive operating cash flow in the past year.
  • Of the past 5 years DCBO 4 years were profitable.
  • Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 18.15%, DCBO belongs to the top of the industry, outperforming 94.60% of the companies in the same industry.
  • DCBO has a Return On Equity of 50.63%. This is amongst the best in the industry. DCBO outperforms 96.04% of its industry peers.
  • DCBO has a better Return On Invested Capital (28.07%) than 96.04% of its industry peers.
  • DCBO had an Average Return On Invested Capital over the past 3 years of 16.11%. This is significantly above the industry average of 10.92%.
  • The 3 year average ROIC (16.11%) for DCBO is below the current ROIC(28.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROIC 28.07%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • DCBO has a better Profit Margin (15.46%) than 82.01% of its industry peers.
  • DCBO's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 12.13%, DCBO is doing good in the industry, outperforming 79.14% of the companies in the same industry.
  • DCBO's Gross Margin of 80.42% is amongst the best of the industry. DCBO outperforms 82.37% of its industry peers.
  • In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DCBO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
  • DCBO has less shares outstanding than it did 1 year ago.
  • DCBO has less shares outstanding than it did 5 years ago.
  • DCBO has a worse debt/assets ratio than last year.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.86 indicates that DCBO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • DCBO has a better Altman-Z score (2.86) than 65.47% of its industry peers.
  • DCBO has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
  • DCBO's Debt to FCF ratio of 0.09 is amongst the best of the industry. DCBO outperforms 80.22% of its industry peers.
  • DCBO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • DCBO's Debt to Equity ratio of 0.03 is in line compared to the rest of the industry. DCBO outperforms 59.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 2.86
ROIC/WACC2.84
WACC9.87%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • DCBO has a Current Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.22, DCBO is not doing good in the industry: 64.39% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.22 indicates that DCBO should not have too much problems paying its short term obligations.
  • DCBO has a Quick ratio of 1.22. This is in the lower half of the industry: DCBO underperforms 63.67% of its industry peers.
  • DCBO does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. DCBO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 56.98% over the past year.
  • Measured over the past years, DCBO shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
  • The Revenue has grown by 11.87% in the past year. This is quite good.
  • Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 30.99% on average per year.
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%

3.2 Future

  • DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.29% yearly.
  • Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 26.95% on average per year.
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. DCBO Valuation Analysis

4.1 Price/Earnings Ratio

  • DCBO is valuated correctly with a Price/Earnings ratio of 12.33.
  • Based on the Price/Earnings ratio, DCBO is valued cheaply inside the industry as 82.73% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 24.88. DCBO is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 10.37 indicates a reasonable valuation of DCBO.
  • Based on the Price/Forward Earnings ratio, DCBO is valued cheaply inside the industry as 83.09% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (22.19), we can say DCBO is valued rather cheaply.
Industry RankSector Rank
PE 12.33
Fwd PE 10.37
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DCBO is valued cheaper than 81.30% of the companies in the same industry.
  • DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 74.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.6
EV/EBITDA 13.4
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of DCBO may justify a higher PE ratio.
  • DCBO's earnings are expected to grow with 20.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y18.91%
EPS Next 3Y20.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCBO Dividend Analysis

5.1 Amount

  • No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCBO Fundamentals: All Metrics, Ratios and Statistics

DOCEBO INC

NASDAQ:DCBO (3/27/2026, 8:10:48 PM)

16.64

-1.04 (-5.88%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners32.89%
Inst Owner Change-4.8%
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap478.57M
Revenue(TTM)242.69M
Net Income(TTM)37.51M
Analysts80
Price Target25.57 (53.67%)
Short Float %7.04%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.78%
Min EPS beat(2)1.01%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)19.42%
Min EPS beat(4)1.01%
Max EPS beat(4)28.07%
EPS beat(8)7
Avg EPS beat(8)27.59%
EPS beat(12)10
Avg EPS beat(12)11.91%
EPS beat(16)13
Avg EPS beat(16)101.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)2
Avg Revenue beat(16)-0.99%
PT rev (1m)-0.7%
PT rev (3m)-6.28%
EPS NQ rev (1m)2.08%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)5.32%
EPS NY rev (3m)5.32%
Revenue NQ rev (1m)3.06%
Revenue NQ rev (3m)3.06%
Revenue NY rev (1m)3.1%
Revenue NY rev (3m)3.1%
Valuation
Industry RankSector Rank
PE 12.33
Fwd PE 10.37
P/S 1.97
P/FCF 17.6
P/OCF 16.99
P/B 6.46
P/tB 8.18
EV/EBITDA 13.4
EPS(TTM)1.35
EY8.11%
EPS(NY)1.61
Fwd EY9.65%
FCF(TTM)0.95
FCFY5.68%
OCF(TTM)0.98
OCFY5.89%
SpS8.44
BVpS2.58
TBVpS2.03
PEG (NY)0.65
PEG (5Y)N/A
Graham Number8.85
Profitability
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROCE 35.53%
ROIC 28.07%
ROICexc 263.9%
ROICexgc N/A
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
FCFM 11.2%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.39%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.06
Cap/Depr 30.79%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 86.37%
Profit Quality 72.49%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.86
F-Score6
WACC9.87%
ROIC/WACC2.84
Cap/Depr(3y)29.27%
Cap/Depr(5y)38.17%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.64%
Profit Quality(3y)239%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%
EBIT growth 1Y55.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.64%
EBIT Next 3Y44.38%
EBIT Next 5Y27.18%
FCF growth 1Y-2.9%
FCF growth 3Y182.43%
FCF growth 5Y48.94%
OCF growth 1Y-3.68%
OCF growth 3Y130.92%
OCF growth 5Y40.42%

DOCEBO INC / DCBO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 7 / 10 to DCBO.


What is the valuation status of DOCEBO INC (DCBO) stock?

ChartMill assigns a valuation rating of 8 / 10 to DOCEBO INC (DCBO). This can be considered as Undervalued.


How profitable is DOCEBO INC (DCBO) stock?

DOCEBO INC (DCBO) has a profitability rating of 8 / 10.


How financially healthy is DOCEBO INC?

The financial health rating of DOCEBO INC (DCBO) is 7 / 10.